LUC+ PDX tumor-bearing mice exhibited negligible weight loss when treated with four weekly administrations of either dose of CNP(MMAE) and when compared to controls (PBS and cisplatin; Fig. 6d). This evidence concerns the gene CNP and neoplasm.